Basic Verification of β-D Glucan in Leukocyte-Rich Plasma for the Diagnosis of Deep Mycosis
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Currently, supplementary serological testing for β-D glucan (BDG) is often selected to diagnose deep mycosis in care covered by the health insurance in Japan. The Wako method used by our center has low sensitivity, and different studies have used different cut-off values due to factors that cause false positives and false negatives. One possible cause of false negatives is the use of platelet-rich plasma (PRP) as the sample material. Because phagocytic white blood cells (WBC) are precipitated by centrifugation and only plasma is measured, it seems unlikely that the actual amount of BDG is being measured when using PRP. Further, a frequent cause of false positives is contamination from blood products and gauze containing BDG. To resolve these issues, the blood cell separator, hydroxyethyl starch, is used to precipitate only the red blood cells to obtain leukocyte-rich plasma (LRP). We hypothesized that it might be possible to improve the diagnostic rate of deep mycosis by measuring the BDG content of plasma containing WBC and fungal components and by comparing the BDG content of PRP and LRP measured simultaneously. Materials and Methods: Healthy human blood, albumin-added blood, wrung-out gauze fluid-added blood, and fungal solution-added blood were prepared, and PRP and LRP were prepared using hydroxyethyl starch. The BDG content of each sample was measured using the Wako method and compared. In addition, PRP and LRP of fungal-added blood were Gramstained and examined under a microscope, and the number of WBCs and phagocytosed fungi was counted visually and compared. Results: Measuring the BDG content of LRP confirmed that there were no false positives with LRP, and in vitro experiments comparing albumin-added false-positive blood to fungal-added blood showed significant differences between PRP and LRP only in the fungal-added blood. Conclusion: Calculating the BDG-ratio (LRP/PRP) by measuring both LRP and PRP may eliminate false positives and false negatives of true deep mycosis and improve the diagnostic rate.
Abstract
Background: Currently, supplementary serological testing for β-D glucan (BDG) is often selected to diagnose deep mycosis in care covered by the health insurance in Japan. The Wako method used by our center has low sensitivity, and different studies have used different cut-off values due to factors that cause false positives and false negatives. One possible cause of false negatives is the use of platelet-rich plasma (PRP) as the sample material. Because phagocytic white blood cells (WBC) are precipitated by centrifugation and only plasma is measured, it seems unlikely that the actual amount of BDG is being measured when using PRP. Further, a frequent cause of false positives is contamination from blood products and gauze containing BDG. To resolve these issues, the blood cell separator, hydroxyethyl starch, is used to precipitate only the red blood cells to obtain leukocyte-rich plasma (LRP). We hypothesized that it might be possible to improve the diagnostic rate of deep mycosis by measuring the BDG content of plasma containing WBC and fungal components and by comparing the BDG content of PRP and LRP measured simultaneously. Materials and Methods: Healthy human blood, albumin-added blood, wrung-out gauze fluid-added blood, and fungal solution-added blood were prepared, and PRP and LRP were prepared using hydroxyethyl starch. The BDG content of each sample was measured using the Wako method and compared. In addition, PRP and LRP of fungal-added blood were Gramstained and examined under a microscope, and the number of WBCs and phagocytosed fungi was counted visually and compared. Results: Measuring the BDG content of LRP confirmed that there were no false positives with LRP, and in vitro experiments comparing albumin-added false-positive blood to fungal-added blood showed significant differences between PRP and LRP only in the fungal-added blood. Conclusion: Calculating the BDG-ratio (LRP/PRP) by measuring both LRP and PRP may eliminate false positives and false negatives of true deep mycosis and improve the diagnostic rate.
참고문헌 (12)
- Obayashi T, "Plasma (1-->3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes", Lancet, 345, pp.17~20 (1995)
- Yoshida K, "Special edition ① Dealing with deep mycosis in surgical emergencies. The usefulness of serodiagnositic methods in the diagnosis of invasive candidiasis", Journal of Japan Society for Surgical Infection, 8, pp.729~735 (2011)
- Mycosis Forum, "Guidelines for management of deep-seated mycoses 2014", pp.127~129 (2014), Kyowa Kikaku Ltd
- Kan S, "Evaluation of an endotoxin-specific limulus amebocyte lysate assay using leukocyte-rich plasma for the diagnosis of gramnegative bacterial infection", J Infect Chemother, 19, pp.299~304 (2013)
- Yoshida K, "Clinical viability of Fungitell, a new (1→3)-β-D: -glucan measurement kit, for diagnosis of invasive fungal infection, and comparison with other kits available in Japan", J Infect Chemother, 17, pp.473~477 (2011)
- Moro H, "Comparison of four diagnostic methods using clinical blood by measuring (1-->3)-beta-D-glucan", Kansenshogaku Zasshi, 77, pp.227~234 (2003)
- Obayashi T, "Validation of a New (1 → 3)-β-DGlucan Test Kit, Fungitec G Test MKⅡ " Nissui "", Med Mycol J, 56, pp.J73~J79 (2015)
- Obayashi T, "Reappraisal of the serum (1-->3)-beta-D-glucan assay for the diagnosis of invasive fungal infections--a study based on autopsy cases from 6 years", Clin Infect Dis, 46, pp.1864~1870 (2008)
- Kan S, "Study on the leukocyte-rich plasma as the specimen for the measurement of endotoxin", Rinsho Byori, 60, pp.1045~1052 (2012)
- Liss B, "1,3-ß-D-glucan concentrations in blood products predict false positive post-transfusion results", Mycoses, 59, pp.39~42 (2016)
- Moro H, "The Effect of Intravenous Gamma-globulin Reagents on the Measurement Results of (1➔3)-β-D-glucan", Kansenshogaku Zasshi, 91, pp.1~6 (2017)
- Prattes J, "Reliability of serum 1,3-beta-D-glucan assay in patients undergoing renal replacement therapy: a review of the literature", Mycoses, 58, pp.4~9 (2015)